Invention Grant
- Patent Title: Hydantoin derivatives as metalloproteinase inhibitors
-
Application No.: US11721586Application Date: 2005-12-14
-
Publication No.: US07655664B2Publication Date: 2010-02-02
- Inventor: Balint Gabos , Michael Lundkvist , Magnus Munck Af Rosenschold , Igor Shamovsky , Pavol Zlatoidsky
- Applicant: Balint Gabos , Michael Lundkvist , Magnus Munck Af Rosenschold , Igor Shamovsky , Pavol Zlatoidsky
- Applicant Address: SE
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE
- Agency: Fish & Richardson P.C.
- Priority: SE0403085 20041217
- International Application: PCT/SE2005/001917 WO 20051214
- International Announcement: WO2006/065215 WO 20060622
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/444
Abstract:
The invention provides compounds of formula (I): wherein R1, R2, A, A1 and B are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
Public/Granted literature
- US20080293743A1 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors Public/Granted day:2008-11-27
Information query
